BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26919118)

  • 1. Hepatic erythropoietin response in cirrhosis. A contemporary review.
    Risør LM; Fenger M; Olsen NV; Møller S
    Scand J Clin Lab Invest; 2016; 76(3):183-9. PubMed ID: 26919118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic erythropoietin response in cirrhosis.
    Risør LM; Fenger M; Olsen NV; Møller S
    Scand J Clin Lab Invest; 2016; 76(3):234-9. PubMed ID: 26924722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
    Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia.
    Siciliano M; Tomasello D; Milani A; Ricerca BM; Storti S; Rossi L
    Hepatology; 1995 Oct; 22(4 Pt 1):1132-5. PubMed ID: 7557862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia.
    Tan CC; Eckardt KU; Firth JD; Ratcliffe PJ
    Am J Physiol; 1992 Sep; 263(3 Pt 2):F474-81. PubMed ID: 1415576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors.
    Nakamatsu K; Nishimura Y; Suzuki M; Kanamori S; Maenishi O; Yasuda Y
    Int J Clin Oncol; 2004 Jun; 9(3):184-8. PubMed ID: 15221603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
    Jensen JD; Jensen LW; Madsen JK; Poulsen L
    Eur J Haematol; 1995 Feb; 54(2):111-6. PubMed ID: 7698293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ontogeny of the biological role and production of erythropoietin.
    Eckardt KU
    J Perinat Med; 1995; 23(1-2):19-29. PubMed ID: 7658316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner.
    Kai S; Tanaka T; Matsuyama T; Suzuki K; Hirota K
    Eur J Pharmacol; 2014 Jun; 732():43-9. PubMed ID: 24680923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis.
    Lönnberg M; Garle M; Lönnberg L; Birgegård G
    J Pharm Biomed Anal; 2013; 81-82():187-92. PubMed ID: 23666255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.
    Tacke F; Schöffski P; Luedde T; Meier PN; Ganser A; Manns MP; Trautwein C
    Scand J Gastroenterol; 2004 Mar; 39(3):259-66. PubMed ID: 15074396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T; Nangaku M
    Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrenal regulation of EPO synthesis.
    Weidemann A; Johnson RS
    Kidney Int; 2009 Apr; 75(7):682-8. PubMed ID: 19165176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin: multiple physiological functions and regulation of biosynthesis.
    Sasaki R; Masuda S; Nagao M
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1775-93. PubMed ID: 11055378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.